Sve~ana akademija - Drustvo Srbije za borbu protiv raka

za mene, kao onkologa i lekara, su koliko
smo qudi obolelih od raka izle~ili. To je
veoma slo`en, kompleksan problem i
pitawe i ne mo`e se re{avati za celokupnu
onkologiju jedne dr`ave.
Ja sam izvadio jedan segment onkologije u
kome sam radio trideset-~etrdeset godina.
To je onkoginekologija. Imamo nekoliko
prospektivnih i retrospektivnih
studija koje dose`u do 1933. godine.
Mislim konkretno na studije primarijusa
Vladete Popovi}a.
Usudio sam se da izdvojim tri studije koje
se odnose na brahiterapiju karcinoma
grli}a i tela materice tokom posledwih
35 do 40 godina XX veka. U tom periodu
smo tretirali oko 35−40.000 takvih pacijenata.
To je najve}a koncentracija klini-
~kog materijala u jednom radiolo{koonkolo{kom
centru na svetu.
Rezultati prve studije su prezentovani na
Tre}em svetskom kongresu radiolo{ke
onkologije u Pekingu 1997. godine. Radi
se o karcinomu grli}a materice. Beograd
je za deset posto postigao boqe rezultate
od prose~nih svetskih rezultata. To je
statisti~ki signifikantno boqi rezultat
od prose~nog svetskog.
Druga studija je izlo`ena na Svetskom
kongresu radiolo{ke onkologije − Melburn
2001. godine. Beograd je postigao za
12% boqe rezultate od prose~nih svetskih
rezultata u le~ewu karcinom tela
materice.
I na kraju, tre}a, prospektivna studija,
prezentovana je u Va{ingtonu na Svetskom
onkolo{kom kongresu 2006. godine u
organizaciji UICC-a gde je bilo prisutno
6000 u~esnika. Sa ovog kongresa, poznati
svetski ~asopis ”Lancet oncology” izdvaja
{est studija i plasira ih na svoje stranice.
Radi se o studijama iz Danske,
Meksika, Indije, Srbije, Francuske i
Rusije. I ova ~iwenica govori o tome gde
se nalazi srpska onkologija, odnosno
radiolo{ka onkologija Srbije.
50
ing? As an oncologist and physician, I see the
results as the number of people we cured.
This is a very complex problem and a question
which cannot be resolved on the level of
entire oncology of one country.
I singled out one segment of oncology, on
which I worked thirty to forty years. It is
called onco-ginecology. We have several
prospective and retrospective studies reaching
back to 1933. By them, I in particular
mean the studies of the Chief Physician,
Vladeta Popovi}.
I dare single out three studies which refer to
the brachyteraphy of cervical cancer and cancer
of uterus during the past 35 - 40 years of
XX century during which we treated 35-
40,000 of such patients. This is the largest
concentration of clinical material in one radiology
and oncology centre in the world.
The first study the results of which were presented
at the third World Congress of radiation
oncology in Peking in 1997, referred to
the cervical cancer. Belgrade achieved results
which were by 10% better than average
international results. This is statistically significantly
better result than the world's average.
The next study was presented at the World
Congress of radiation oncology held in
Melbourne in 2001. Belgrade achieved
results which were by 12% better than average
international results in curing the carcinoma
of uterus body.
And finally the third, prospective study presented
in Washington at the World Congress
about oncology, held in 2006, which was
organized by UICC, and attended by 6,000
people. From this congress, the world's
renowned journal "Lancet Oncology" highlighted
six studies and published them on
their pages. These are the studies of
Denmark, Mexico, India, Serbia, France and
Russia. This mirrors the place of Serbian
oncology at this point - in particular, the radiation
oncology.